Subscribe To Our Newsletter
Abonnez-vous à notre bulletin
ROUND FIVE DECISIONS
GFO Issue 51

ROUND FIVE DECISIONS

Author:

Bernard Rivers

Article Type:
News

Article Number: 4

ABSTRACT A detailed listing and analysis is provided of which Round 5 proposals have been approved.

Based on advise from the Technical Review Panel (TRP), the Board divides eligible proposals into five Categories, as follows:

  • Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 4 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
  • Category 2A: Proposals that are provisionally approved subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to respond to the TRP queries, 4 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer and secondary reviewer as well as TRP Chair and /or Vice-Chair need to give final approval.
  • Category 2B: Similar to Category 2A, but regarded as relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation. The TRP took no account of the applicant country’s income level, nor of burden of disease nor of any factors other than technical merit and feasibility in grading a proposal as Category 2B. In other words, these proposals differ from Category 2A proposals only in that they have more technical weaknesses, and/or more questions as to effective implementation, and/or more required clarifications. It is important to note, however, that on balance all of the Category 2B proposals were regarded as recommended for funding, and the TRP believes that the weaknesses and clarifications could be addressed within the timeframes provided for Category 2A proposals.
  • Category 3: Not approved in their present form, but applicants are encouraged to submit an improved proposal in some future Round.
  • Category 4: Rejected.

If the Fund had sufficient pledges for 2005 to cover the cost of all Category 1, 2A and 2B proposals, it would have approved all of them at last week’s meeting, subject to the applicants responding acceptably to the TRP’s requests for clarification that will be sent to the applicants.

However, given that the Fund currently has insufficient pledges to cover all the Category 1, 2A and 2B proposals, the board agreed to proceed as follows, using a procedure specified at an earlier board meeting:

  • Category 1 proposals are approved.
  • Category 2A and 2B proposals are given a “Composite Index” of between 1 and 8 points, as follows:
  • If the country has a “very high” disease burden, it receives 4 points, and otherwise it receives 1 point.
  • In addition, if the country is “low-income” it receives 4 points, and if it is “lower-middle income” it receives 2 points. (“Upper-middle income” countries receive 0 extra points.)

Proposals were ranked by Category and then, for Categories 2A and 2B, they were sub-ranked by Composite Index. This led to them being grouped as in Table 5, below.

The Fund currently has enough pledges to pay for the first three groups. These have been labeled by GFO as “Immediately Approved: A, B and C”. Proposals that fall into these three groups are approved, subject to satisfactory responses being provided to the TRP queries.

The Fund does not currently have sufficient pledges to pay for proposals in the next eight groups, labeled by GFO as “Provisionally Approved D, E, F, G, H, I, J and K”. When the Fund received pledges sufficient to cover each additional group (in the order shown below), the board will approve those proposals by email.

The Secretariat will start working immediately with all provisionally approved applicants on dealing with TRP queries and negotiating grant agreements. If all those activities have been completed before pledges and actual cash contributions have been received, the actual signing of grant agreements will have to be put on hold.

However, provisionally approved proposals for which insufficient pledges are received by the end of June 2006 will lose their provisional approval and will be treated as if they had not been approved.

Table 5: Round 5 results by Category

Decision Explanation Number of proposals Budget

Years 1-2

Budget

Years 1-5

Immediately Approved: A Category 1 5 $43,310,437 $98,935,651
Immediately Approved: B Category 2A, Composite Index 8 18 $290,762,706 $728,609,400
Immediately Approved: C Category 2A, Composite Index 6 3 $48,003,918 $149,563,776
Subtotal: All “Immediately Approved” proposals 26 $382,077,061 $977,108,827
Provisionally approved: D Category 2A, Composite Index 5 12 $133,276,403 $345,346,815
Provisionally approved: E Category 2A, Composite Index 4 2 $9,529,070 $24,888,718
Provisionally approved: F Category 2A, Composite Index 3 13 $92,575,047 $165,266,161
Provisionally approved: G Category 2B, Composite Index 8 4 $87,358,034 $207,352,569
Provisionally approved: H Category 2B, Composite Index 7 1 $3,269,731 $6,623,560
Provisionally approved: I Category 2B, Composite Index 6 1 $6,501,141 $21,232,348
Provisionally approved: J Category 2B, Composite Index 5 2 $3,356,219 $6,868,700
Provisionally approved: K Category 2B, Composite Index 3 2 $7,673,482 $19,814,848
Subtotal: All “Provisionally Approved” proposals 37 $343,539,127 $797,393,719
Total: All “Immediately Approved” plus “Provisionally Approved” proposals 63 $725,616,188 $1,774,502,546
Not approved: L Category 3 120 $2,266,242,296 $5,096,656,571
Not approved: M Category 4 19 $306,210,534 $750,510,205
Subtotal: All “Not Approved” proposals 139 $2,572,452,830 $5,847,166,776
GRAND TOTAL 202 $3,298,069,018 $7,621,669,322

Table 6: Round 5 results by country

Country

Applicant

Decision

(See definitions above)

Component

Budget
Years 1-2

Budget
Years 1-5

Afghanistan CCM Provisionally approved: D Malaria

$17,093,334

$32,214,069

Afghanistan CCM Not approved: L HIV/AIDS

$4,663,653

$10,953,024

Afghanistan CCM Not approved: L HSS

$1,980,090

$4,014,470

Albania CCM Provisionally approved: F HIV/AIDS

$2,502,858

$4,990,645

Albania CCM Provisionally approved: F TB

$877,685

$1,442,028

Angola CCM Not approved: L Malaria

$39,227,228

$115,827,277

Armenia CCM Provisionally approved: K TB

$3,898,656

$7,624,135

Armenia CCM Not approved: M Malaria

$1,705,100

$2,572,700

Azerbaijan CCM Immediately Approved: A TB

$3,825,770

$9,516,200

Azerbaijan CCM Not approved: L Malaria

$3,179,532

$7,255,952

Bangladesh CCM Immediately Approved: B TB

$10,003,984

$45,977,231

Bangladesh CCM Not approved: L HIV/AIDS

$8,135,641

$23,901,394

Bangladesh CCM Not approved: L Malaria

$18,478,606

$36,993,988

Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka Regional CM Not approved: M HIV/AIDS

$15,464,067

$59,842,897

Belarus CCM Not approved: L TB

$13,239,086

$26,389,516

Benin CCM Provisionally approved: D HIV/AIDS

$19,709,054

$51,841,972

Benin CCM Not approved: L HSS

$6,560,978

$12,130,576

Benin CCM Not approved: L Malaria

$10,714,920

$52,930,467

Benin CCM Not approved: L TB

$3,575,918

$7,793,321

Benin, Cote d’Ivoire, Ethiopia, Nigeria, Zimbabwe Regional org. (PSI and African Union) Not approved: M HIV/AIDS

$17,304,394

$44,804,606

Bosnia Herzegovina CCM Provisionally approved: F HIV/AIDS

$4,832,387

$11,042,257

Bosnia Herzegovina CCM Not approved: L TB

$1,171,290

$3,157,230

Botswana CCM Provisionally approved: E TB

$5,515,900

$8,956,258

Brazil CCM Immediately Approved: C TB

$11,602,427

$27,240,000

Burkina Faso CCM Not approved: L HIV/AIDS

$34,432,357

$71,569,383

Burkina Faso CCM Not approved: L HSS

$5,845,718

$9,170,885

Burkina Faso CCM Not approved: L Malaria

$19,208,881

$27,152,602

Burundi CCM Provisionally approved: G HIV/AIDS

$13,053,866

$32,353,173

Burundi CCM Not approved: L HSS

$2,370,296

$6,566,203

Burundi CCM Not approved: L Malaria

$12,215,162

$25,401,464

Cambodia CCM Immediately Approved: B TB

$3,268,750

$9,662,024

Cambodia CCM Provisionally approved: D HIV/AIDS

$16,292,779

$34,963,654

Cambodia CCM Provisionally approved: G HSS

$1,841,600

$5,015,741

Cambodia CCM Not approved: L Malaria

$5,854,119

$11,824,545

Cameroon CCM Immediately Approved: B HIV/AIDS

$4,943,590

$12,060,019

Cameroon CCM Immediately Approved: B Malaria

$12,695,885

$21,210,595

Cape Verde CCM Not approved: L HIV/AIDS

$4,313,270

$11,659,200

Central African Republic CCM Not approved: L HIV/AIDS

$22,082,191

$36,632,357

Central African Republic CCM Not approved: L Malaria

$7,598,940

$11,990,390

Chad CCM Not approved: L Malaria

$17,335,833

$36,713,126

China CCM Immediately Approved: C TB

$17,814,000

$52,889,000

China CCM Provisionally approved: F HIV/AIDS

$12,544,128

$28,902,074

China CCM Provisionally approved: F Malaria

$20,096,149

$39,410,395

Colombia CCM Not approved: L HIV/AIDS

$13,338,388

$29,356,545

Comoros CCM Not approved: L Malaria

$4,110,188

$7,727,600

Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama Regional org. (Secretary of Social Integration of Central America – SSICA) Not approved: M HIV/AIDS

$13,859,280

$30,722,300

Cote d’Ivoire Non-CCM (CARE) Immediately Approved: B HIV/AIDS

$3,522,695

$3,522,695

Cote d’Ivoire CCM Not approved: L HIV/AIDS

$26,836,531

$47,022,390

Cote d’Ivoire CCM Not approved: L Malaria

$7,897,631

$20,272,415

Dem. Rep. Congo CCM Immediately Approved: B TB

$17,613,606

$43,716,984

Dem. Rep. Congo CCM Not approved: L HIV/AIDS

$60,848,374

$142,154,402

Dem. Rep. Congo CCM Not approved: L HSS

$17,947,453

$40,244,494

Dem. Rep. Congo CCM Not approved: L Malaria

$21,184,713

$38,608,576

Dem. Rep. Congo – Kasai Sub-CCM Not approved: M HIV/AIDS

$66,831,110

$127,046,138

Dem. Rep. Congo – Kasai Sub-CCM Not approved: M Malaria

$16,564,000

$29,779,000

Dem. Rep. Congo – Kasai Sub-CCM Not approved: M TB

$12,702,000

$23,507,000

Djibouti CCM Not approved: L Malaria

$2,344,000

$5,113,000

Djibouti CCM Not approved: L TB

$4,819,773

$10,704,374

Dominican Republic CCM Not approved: L Malaria

$5,368,399

$11,914,220

East Timor CCM Provisionally approved: D HIV/AIDS

$4,304,454

$9,110,302

Ecuador CCM Not approved: L Malaria

$4,097,749

$4,097,749

Egypt CCM Not approved: L HIV/AIDS

$2,185,934

$6,201,772

Egypt CCM Not approved: L TB

$4,588,252

$11,085,278

Egypt CCM Not approved: M Malaria

$2,380,000

$5,000,000

El Salvador CCM Not approved: L Malaria

$1,100,000

$3,000,000

Equatorial Guinea CCM Not approved: L Malaria

$12,906,111

$25,999,072

Eritrea CCM Provisionally approved: D HIV/AIDS

$13,139,010

$33,892,005

Eritrea CCM Not approved: L HSS

$7,697,965

$14,435,485

Eritrea CCM Not approved: L Malaria

$8,844,992

$17,200,208

Eritrea CCM Not approved: L TB

$1,443,404

$3,879,324

Ethiopia CCM Provisionally approved: G Malaria

$64,548,913

$150,066,528

Ethiopia CCM Not approved: L HIV/AIDS

$23,145,990

$64,497,352

Ethiopia CCM Not approved: L HSS

$159,999,343

$348,014,355

Ethiopia CCM Not approved: L TB

$16,440,576

$69,882,371

Gabon CCM Provisionally approved: E Malaria

$4,013,170

$15,932,460

Georgia CCM Not approved: L HIV/AIDS

$2,797,640

$4,654,240

Georgia CCM Not approved: L HSS

$436,320

$814,320

Ghana CCM Immediately Approved: A TB

$14,547,546

$31,471,844

Ghana CCM Provisionally approved: D HIV/AIDS

$31,630,830

$97,099,610

Ghana CCM Not approved: L HSS

$12,552,761

$19,359,341

Ghana, Uganda, Zimbabwe Regional org. (TEPHINET) Not approved: M HSS

$16,363,767

$36,318,213

Guatemala CCM Not approved: L TB

$5,826,331

$11,623,999

Guinea CCM Immediately Approved: A TB

$3,391,501

$6,225,144

Guinea CCM Not approved: L Malaria

$3,467,563

$18,987,568

Haiti CCM Immediately Approved: B HIV/AIDS

$19,205,567

$49,927,069

India CCM Not approved: L Malaria

$14,742,454

$26,448,410

India CCM Not approved: L TB

$7,410,000

$25,020,000

India CCM Not approved: M HIV/AIDS

$67,620,403

$217,625,981

Indonesia CCM Immediately Approved: C TB

$18,587,491

$69,434,776

Indonesia CCM Not approved: L HIV/AIDS

$13,671,879

$26,117,640

Indonesia CCM Not approved: L Malaria

$43,145,932

$66,543,849

Iran CCM Not approved: L Malaria

$8,500,000

$18,600,000

Jordan CCM Provisionally approved: F TB

$1,072,864

$2,782,864

Jordan CCM Not approved: L HIV/AIDS

$3,588,958

$6,899,718

Kazakhstan CCM Not approved: L HIV/AIDS

$2,000,295

$4,814,539

Kazakhstan CCM Not approved: L TB

$8,375,651

$17,558,542

Kenya CCM Provisionally approved: G TB

$7,913,655

$19,917,127

Kenya CCM Not approved: L HIV/AIDS

$8,893,681

$19,796,832

Kenya CCM Not approved: L HSS

$11,179,083

$28,076,553

Kenya CCM Not approved: L Malaria

$4,230,600

$8,427,600

Kosovo CCM Not approved: L HIV/AIDS

$1,701,158

$3,687,350

Kyrgyzstan CCM Provisionally approved: D Malaria

$1,692,390

$3,426,125

Kyrgyzstan CCM Not approved: L TB

$5,309,127

$8,863,698

Lesotho CCM Immediately Approved: B HIV/AIDS

$10,013,383

$40,346,059

Liberia CCM Not approved: L HIV/AIDS

$12,394,177

$25,714,627

Liberia CCM Not approved: L HSS

$14,078,615

$17,374,573

Liberia CCM Not approved: L Malaria

$15,015,748

$33,165,706

Liberia CCM Not approved: L TB

$4,750,966

$11,949,773

Macedonia CCM Provisionally approved: F TB

$1,442,489

$3,071,097

Madagascar CCM Not approved: L HIV/AIDS

$9,512,412

$24,957,422

Madagascar CCM Not approved: L HSS

$4,965,759

$22,599,312

Madagascar CCM Not approved: L Malaria

$7,974,500

$33,470,801

Madagascar CCM Not approved: L TB

$8,900,519

$15,249,703

Malawi CCM Immediately Approved: B HIV/AIDS

$7,770,655

$19,104,775

Malawi CCM Immediately Approved: B HSS

$26,965,524

$65,429,986

Maldives CCM Not approved: M HIV/AIDS

$2,016,601

$4,184,665

Mali CCM Not approved: L HSS

$7,083,766

$11,600,785

Mali CCM Not approved: L Malaria

$14,862,149

$36,069,482

Mauritania CCM Provisionally approved: D HIV/AIDS

$6,584,973

$15,755,931

Mongolia CCM Provisionally approved: D HIV/AIDS

$1,898,775

$4,235,640

Montenegro CCM Provisionally approved: F HIV/AIDS

$1,604,606

$2,924,696

Mozambique CCM Not approved: L HSS

$72,100,000

$106,600,000

Mozambique CCM Not approved: L Malaria

$32,694,480

$73,121,487

Mozambique, South Africa, Swaziland Regional CM Provisionally approved: I Malaria

$6,501,141

$21,232,348

Namibia CCM Immediately Approved: A TB

$7,222,753

$17,777,383

Namibia CCM Not approved: L HIV/AIDS

$31,341,874

$91,950,544

Namibia CCM Not approved: L Malaria

$13,136,240

$21,897,490

Nepal CCM Not approved: L HIV/AIDS

$7,717,233

$25,788,007

Nepal CCM Not approved: L Malaria

$5,352,822

$11,372,370

Nepal CCM Not approved: L TB

$3,858,926

$9,481,273

Niger CCM Immediately Approved: B Malaria

$5,148,600

$10,491,196

Niger CCM Provisionally approved: D TB

$6,326,070

$12,220,815

Niger CCM Not approved: L HSS

$7,529,467

$11,474,188

Nigeria CCM Immediately Approved: B HIV/AIDS

$46,424,283

$180,642,512

Nigeria CCM Immediately Approved: B TB

$19,217,311

$53,351,149

Nigeria CCM Not approved: L HSS

$39,505,341

$64,812,236

Nigeria CCM Not approved: L Malaria

$52,404,797

$179,995,004

Pakistan CCM Not approved: L HIV/AIDS

$13,000,477

$34,989,566

Pakistan CCM Not approved: L Malaria

$11,293,294

$27,059,519

Pakistan CCM Not approved: L TB

$15,854,040

$30,308,701

Pakistan CCM Not approved: M HSS

$9,977,880

$26,617,490

Papua New Guinea CCM Not approved: L TB

$1,975,954

$10,784,888

Paraguay CCM Not approved: M HIV/AIDS

$3,941,134

$9,429,262

Peru CCM Provisionally approved: F HIV/AIDS

$9,874,896

$12,967,865

Peru CCM Provisionally approved: F TB

$21,017,537

$32,545,545

Peru CCM Not approved: L HSS

$6,894,200

$17,011,200

Philippines CCM Provisionally approved: F HIV/AIDS

$3,011,919

$6,478,058

Philippines CCM Provisionally approved: F Malaria

$11,097,529

$14,308,637

Philippines CCM Not approved: L TB

$14,208,812

$45,817,584

Republic of Congo CCM Provisionally approved: D HIV/AIDS

$12,043,407

$45,553,763

Republic of Congo CCM Not approved: L Malaria

$17,664,123

$28,331,791

Republic of Congo CCM Not approved: L TB

$4,669,340

$8,138,467

Russian Federation Non-CCM Provisionally approved: K HIV/AIDS

$3,774,826

$12,190,713

Rwanda CCM Immediately Approved: A HSS

$14,322,867

$33,945,080

Rwanda CCM Immediately Approved: B Malaria

$28,140,772

$39,649,363

Rwanda CCM Not approved: L HIV/AIDS

$36,053,491

$88,300,796

Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu Regional Coordinating Mechanism Not approved: L HIV/AIDS

$4,251,406

$9,946,332

Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu Regional Coordinating Mechanism Not approved: L TB

$1,466,940

$4,432,060

Sao Tome & Principe CCM Provisionally approved: J HIV/AIDS

$584,218

$1,485,190

Senegal CCM Not approved: L TB

$8,725,379

$18,336,573

Senegal CCM Not approved: M HSS

$2,321,013

$3,384,233

Senegal CCM Not approved: M Malaria

$8,251,057

$12,117,141

Serbia CCM Not approved: L HIV/AIDS

$4,755,306

$8,462,528

Solomon Islands, Vanuatu Regional Coordinating Mechanism Provisionally approved: H Malaria

$3,269,731

$6,623,560

Somalia Non-CCM Not approved: L HSS

$1,175,365

$2,832,730

Somalia Non-CCM Not approved: L Malaria

$2,567,445

$14,532,272

South Africa CCM Not approved: L HIV/AIDS

$45,010,000

$108,289,000

South Africa CCM Not approved: L HSS

$21,851,000

$42,173,000

Sri Lanka CCM Not approved: L Malaria

$4,356,374

$7,290,124

Sri Lanka CCM Not approved: L TB

$1,700,680

$4,414,795

Sri Lanka CCM Not approved: M HIV/AIDS

$2,607,594

$5,357,285

Sudan CCM Not approved: L HIV/AIDS

$29,424,335

$112,553,275

Sudan CCM Not approved: L Malaria

$24,019,599

$46,323,995

Sudan CCM Not approved: L TB

$6,830,013

$15,410,468

Sudan CCM Not approved: M HSS

$42,800,000

$105,860,000

Sudan (Southern Sector) Sub-CCM Immediately Approved: B TB

$8,592,197

$27,568,526

Sudan (Southern Sector) Sub-CCM Not approved: L HSS

$25,929,249

$68,455,557

Suriname CCM Provisionally approved: F HIV/AIDS

$2,600,000

$4,400,000

Tajikistan CCM Provisionally approved: J Malaria

$2,772,001

$5,383,510

Tanzania CCM Not approved: L HIV/AIDS

$9,204,276

$11,932,883

Tanzania CCM Not approved: L HSS

$22,869,642

$34,866,750

Tanzania Zanzibar CCM Not approved: L HIV/AIDS

$12,722,287

$30,817,709

Thailand CCM Not approved: L HIV/AIDS

$5,920,079

$16,886,287

The Gambia CCM Provisionally approved: D TB

$2,561,327

$5,032,929

The Gambia CCM Not approved: L HIV/AIDS

$7,842,275

$14,733,869

The Gambia CCM Not approved: L Malaria

$18,169,122

$40,473,141

Tunisia CCM Not approved: L HIV/AIDS

$10,007,400

$20,898,000

Turkey CCM Not approved: M Malaria

$2,387,990

$4,784,490

Turkey CCM Not approved: M TB

$1,113,144

$1,556,804

Uganda CCM Not approved: L HIV/AIDS

$5,857,397

$17,746,651

Uganda CCM Not approved: L HSS

$5,605,994

$10,942,316

Uganda CCM Not approved: L Malaria

$49,494,235

$90,219,700

Vietnam CCM Not approved: L HIV/AIDS

$6,500,000

$20,000,000

Vietnam CCM Not approved: L TB

$7,037,112

$18,718,344

Yemen CCM Not approved: L Malaria

$15,889,956

$41,763,366

Zambia CCM Not approved: L HIV/AIDS

$481,308,000

$1,033,420,000

Zambia CCM Not approved: L HSS

$11,042,000

$34,940,000

Zambia CCM Not approved: L Malaria

$22,147,000

$41,200,000

Zambia CCM Not approved: L TB

$98,610,000

$246,525,000

Zimbabwe CCM Immediately Approved: B HIV/AIDS

$35,931,159

$62,478,891

Zimbabwe CCM Immediately Approved: B Malaria

$21,217,469

$29,998,400

Zimbabwe CCM Immediately Approved: B TB

$10,087,276

$13,471,926

 

Information on Round 5 grants is also available on the Global Fund web site at www.theglobalfund.org/en/about/board/eleventh.

 

An applicant may appeal the board’s decision if the applicant submitted an eligible proposal for a particular component in both Round 4 and Round 5 and was not approved in either case. The appeal must show that the recommendation made by the TRP regarding the Round 5 proposal was based on a “significant and obvious” error. The appeal must be filed with the Secretariat no later than 28 days from when the applicant receives written notice of the board’s Round 5 decision. For further details regarding the appeals procedure, see www.theglobalfund.org/en/apply/proposals/appeals.

Leave a Reply

Your email address will not be published.

Aidspan

Categories*

Loading
Aidspan

Categories*

Loading